Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 21749691)

1.

Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review.

Banura C, Mirembe FM, Katahoire AR, Namujju PB, Mbonye AK, Wabwire FM.

Infect Agent Cancer. 2011 Jul 12;6(1):11. doi: 10.1186/1750-9378-6-11.

2.

Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.

ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X, et al.

Int J Cancer. 1992 Jun 19;51(4):515-21.

PMID:
1318265
3.

Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation.

Taube JM, Kamira B, Motevalli M, Nakabiito C, Lukande R, Kelly DP, Erozan YS, Gravitt PE, Buresh ME, Mmiro F, Bagenda D, Guay LA, Jackson JB.

Diagn Cytopathol. 2010 Aug;38(8):555-63. doi: 10.1002/dc.21249.

PMID:
19937939
4.

Infection with human papillomavirus and HIV among young women in Kampala, Uganda.

Banura C, Franceschi S, Doorn LJ, Arslan A, Wabwire-Mangen F, Mbidde EK, Quint W, Weiderpass E.

J Infect Dis. 2008 Feb 15;197(4):555-62. doi: 10.1086/526792.

5.
6.

The relationship between contraceptives, sexual practices, and cervical human papillomavirus infection among a college population.

Burkett BJ, Peterson CM, Birch LM, Brennan C, Nuckols ML, Ward BE, Crum CP.

J Clin Epidemiol. 1992 Nov;45(11):1295-302.

PMID:
1331341
7.
8.

Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.

Videla S, Darwich L, Cañadas MP, Paredes R, Tarrats A, Castella E, Llatjos M, Bofill M, Clotet B, Sirera G; HIV-HPV Study Group.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):168-75. doi: 10.1097/QAI.0b013e3181938e63.

PMID:
19131892
9.

Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.

Banura C, Sandin S, van Doorn LJ, Quint W, Kleter B, Wabwire-Mangen F, Mbidde EK, Weiderpass E.

Infect Agent Cancer. 2010 Apr 9;5:7. doi: 10.1186/1750-9378-5-7.

10.

Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy).

Masia G, Mazzoleni AP, Contu G, Laconi S, Minerba L, Montixi S, Montis F, Onano A, Porcedda E, Coppola RC.

Vaccine. 2009 May 29;27 Suppl 1:A11-6. doi: 10.1016/j.vaccine.2008.10.095.

PMID:
19480954
11.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Review. French.

PMID:
18786806
12.

Molecular epidemiology of human papillomavirus genotype in women with high-grade squamous intraepithelial lesion and cervical cancer: will a quadrivalent vaccine be necessary in Thailand?

Sukasem C, Pairoj W, Saekang N, Pombubpha H, Srichunrasami C, Pongtippan A, Junyangdikul P, Chantratita W.

J Med Virol. 2011 Jan;83(1):119-26. doi: 10.1002/jmv.21948.

PMID:
21108348
13.

High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda.

Tobian AA, Grabowski MK, Kigozi G, Gravitt PE, Eaton KP, Serwadda D, Nalugoda F, Wawer MJ, Quinn TC, Gray RH.

Sex Transm Infect. 2013 Mar;89(2):122-7. doi: 10.1136/sextrans-2012-050524. Epub 2012 May 24.

14.

Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study.

Dartell M, Rasch V, Kahesa C, Mwaiselage J, Ngoma T, Junge J, Gernow A, Ejlersen SF, Munk C, Iftner T, Kjaer SK.

Sex Transm Dis. 2012 Mar;39(3):201-8. doi: 10.1097/OLQ.0b013e31823b50ad.

PMID:
22337107
15.

Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.

Syrjänen KJ.

Scand J Infect Dis Suppl. 2009;107:3-32. doi: 10.1080/00365540902887730. Review.

PMID:
19408160
16.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. doi: 10.1093/jnci/djn510. Epub 2009 Mar 24.

17.

HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study.

Odida M, Sandin S, Mirembe F, Kleter B, Quint W, Weiderpass E.

Infect Agent Cancer. 2011 Jun 25;6(1):8. doi: 10.1186/1750-9378-6-8.

18.

Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis.

Banura C, Mirembe FM, Orem J, Mbonye AK, Kasasa S, Mbidde EK.

Infect Agent Cancer. 2013 Jul 10;8(1):27. doi: 10.1186/1750-9378-8-27.

19.

Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia.

Alibegashvili T, Clifford GM, Vaccarella S, Baidoshvili A, Gogiashvili L, Tsagareli Z, Kureli I, Snijders PJ, Heideman DA, van Kemenade FJ, Meijer CJ, Kordzaia D, Franceschi S.

Cancer Epidemiol. 2011 Oct;35(5):465-70. doi: 10.1016/j.canep.2010.12.006. Epub 2011 Feb 2.

PMID:
21292583
20.

Oncogenic HPV among HIV infected female population in West Bengal, India.

Sarkar K, Pal R, Bal B, Saha B, Bhattacharya S, Sengupta S, Mazumdar PP, Chakraborti S.

BMC Infect Dis. 2011 Mar 22;11:72. doi: 10.1186/1471-2334-11-72.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk